Abstract
Protein phosphorylation is a critical cellular process regulated by the competing actions of protein kinases (PKs) and phosphatases (PPs). While several hundred PKs exist in mammalian cells, there are only a few dozen PPs. PPs typically target Ser/Thr or Tyr residues but each has different characteristics and specificities and fall into three separate classes. PPs on their own have poor substrate specificity, however, when bound to regulatory proteins their activity and specificity is tightly controlled. Mechanisms of PP regulation range from targeting to subcellular compartments by scaffolding proteins and/or protein complexes which restrict the action of PPs to specific substrates, to the inhibition of PPs by specific inhibitory molecules or inhibitor peptides. In the adult brain, PPs are essential for synaptic functions and are involved in the negative regulation of higher-order brain functions such as learning and memory. Dysregulation of their activity has been linked to several disorders including cognitive ageing and neurodegeneration, but also cancer, diabetes and obesity. Because they are critical for multiple biological functions and could constitute a new class of drug targets, they deserve to be studied in greater detail. The complexity of their modes of action and of the systems they function in, however, requires the analysis of whole systems rather than of individual proteins in isolation, as has been the case for decades using classical molecular biology. In this review, we discuss PPs in the context of the central nervous system, their role in neuronal functions, and their regulation and dysfunction in disease. Current techniques to investigate PP signalling and associated functional networks, future directions for the development of system-wide proteomic and genomic methods of analysis, and the potential for therapeutic applications are also covered.
Ry Y. Tweedie-Cullen and C.S. Park contributed equally for this chapter
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CaM:
-
Calmodulin
- CaMKII:
-
Ca2+/calmodulin-dependent kinase II
- CDK:
-
Cyclin-dependent kinase
- ChIP:
-
Chromatin immunoprecipitation
- ChIP-Seq:
-
Chromatin immunoprecipitation followed by sequencing
- CNS:
-
Central nervous system
- DSP/DUSP:
-
Dual-specificity phosphatases
- HAD:
-
haloacid dehydrogenase
- HDAC:
-
Histone deacetylase
- I1:
-
Inhibitor 1
- KIM:
-
kinase interaction motif
- LMPTP/LMWPTP:
-
18 kDa low MW phosphatase
- LTP:
-
Long-term potentiation
- MKP:
-
MAPK phosphatase
- MS:
-
Mass spectrometry
- MTM:
-
Myotubularin
- MTMR:
-
MTM1-related
- NIPP1:
-
Nuclear inhibitor of protein phosphatase 1
- NRPTP:
-
Non-receptor PTP
- PKA:
-
Protein kinase A
- PK:
-
Protein kinase
- PP:
-
Protein phosphatase
- PP1:
-
Protein phosphatase 1
- PP2B:
-
Calcineurin
- PPM:
-
Protein phosphatase Mg2+- or Mn2+-dependent
- PPP:
-
Phosphoprotein phosphatase
- PTEN:
-
Phosphatase and tensin homolog deleted in chromosome 10
- PTK:
-
Protein tyrosine kinase
- PTM:
-
Posttranslational modification
- PTP:
-
Protein tyrosine phosphatases
- PTP-SL:
-
Protein tyrosine phosphatase STEP-like
- pSer/pThr/pTyr:
-
Phosphorylated-serine/-threonine/-tyrosine
- RLPTP:
-
Receptor-like PTP
- ROS:
-
Reactive oxygen species
- RPTP:
-
Receptor PTP
- Ser/Thr/Tyr:
-
Serine/threonine/tyrosine
- SHP:
-
Src-homology domain containing phosphatase
- STEP:
-
Striatal-enriched phosphatase
References
Allis, C.D., Berger, S.L., Cote, J., et al. (2007). New nomenclature for chromatin-modifying enzymes. Cell 131:633–636.
Alonso, A., Sasin, J., Bottini, N., et al. (2004). Protein tyrosine phosphatases in the human genome. Cell 117:699–711.
Andersen, J.N., Jansen, P.G., Echwald, S.M., et al. (2004). A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18:8–30.
Aricescu, A.R., McKinnell, I.W., Halfter, W., et al. (2002). Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 22:1881–1892.
Aricescu, A.R., Siebold, C., Choudhuri, K., et al. (2007). Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science 317:1217–1220.
Atkins, C.M., Davare, M.A., Oh, M.C., et al. (2005). Bidirectional regulation of cytoplasmic polyadenylation element-binding protein phosphorylation by Ca2+/calmodulin-dependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation. J. Neurosci. 25:5604–5610.
Barford, D., Das, A.K., and Egloff, M.P. (1998). The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu. Rev. Biophys. Biomol. Struct. 27:133–164.
Bauman, A.L. and Scott, J.D. (2002). Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo. Nat. Cell Biol. 4:E203–206.
Baumgartel, K., Fernandez, C., Johansson, T., et al. (2007). Conditional transgenesis and recombination to study the molecular mechanisms of brain plasticity and memory. Handb. Exp. Pharmacol. 3:315–345.
Baumgartel, K., Genoux, D., Welzl, H., et al. (2008). Control of the establishment of aversive memory by calcineurin and Zif268. Nat. Neurosci. 11:572–578.
Bellinzoni, M., Wehenkel, A., Shepard, W., et al. (2007). Insights into the catalytic mechanism of PPM Ser/Thr phosphatases from the atomic resolution structures of a mycobacterial enzyme. Structure 15:863–872.
Bialy, L. and Waldmann, H. (2005). Inhibitors of protein tyrosine phosphatases: next-generation drugs? Angew Chem. Int. Ed. Engl. 44:3814–3839.
Bilwes, A.M., den Hertog, J., Hunter, T., et al. (1996). Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382:555–559.
Birle, D., Bottini, N., Williams, S., et al. (2002). Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. J. Immunol. 169:286–291.
Bito, H., Deisseroth, K., and Tsien, R.W. (1996). CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203–1214.
Blanchetot, C., Chagnon, M., Dube, et al. (2005). Substrate-trapping techniques in the identification of cellular PTP targets. Methods 35:44–53.
Boggon, T.J., Murray, J., Chappuis-Flament, S., et al. (2002). C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 296:1308–1313.
Bolino, A., Muglia, M., Conforti, F.L., et al. (2000). Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25:17–19.
Bolis, A., Coviello, S., Bussini, S., et al. (2005). Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J. Neurosci. 25:8567–8577.
Bottini, N., Borgiani, P., Otsu, A., et al. (2002). IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs. Clin. Genet. 61:288–292.
Boulanger, L.M., Lombroso, P.J., Raghunathan, A., et al. (1995). Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci. 15:1532–1544.
Bradshaw, J.M., Kubota, Y., Meyer, T., et al. (2003). An ultrasensitive Ca2+/calmodulin-dependent protein kinase II-protein phosphatase 1 switch facilitates specificity in postsynaptic calcium signaling. Proc. Natl. Acad. Sci. USA 100:10512–10517.
Brady-Kalnay, S.M., Flint, A.J., et al. (1993). Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. J. Cell Biol. 122, 961–972.
Bucciantini, M., Chiarugi, P., Cirri, P., et al. (1999). The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase. FEBS Lett. 456, 73–78.
Buj-Bello, A., Furling, D., Tronchere, H., et al. (2002). Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 11, 2297–2307.
Burnett, P.E., Blackshaw, S., Lai, M.M., et al. (1998). Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc. Natl. Acad. Sci. USA 95:8351–8356.
Canettieri, G., Morantte, I., Guzman, E., et al. (2003). Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol. 10:175–181.
Ceulemans, H. and Bollen, M. (2004). Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84:1–39.
Chen, G.I. and Gingras, A.C. (2007). Affinity-purification mass spectrometry (AP-MS) of serine/threonine phosphatases. Methods 42:298–305.
Chen, M., Hou, X., and Zhang, G. (2003). Tyrosine kinase and tyrosine phosphatase participate in regulation of interactions of NMDA receptor subunit 2A with Src and Fyn mediated by PSD-95 after transient brain ischemia. Neurosci. Lett. 339:29–32.
Chong, S. and Whitelaw, E. (2004). Epigenetic germline inheritance. Curr. Opin. Genet. Dev. 14:692–696.
Chwang, W.B., O’Riordan, K.J., Levenson, J.M., et al. (2006). ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn. Mem. 13:322–328.
Coghlan, V.M., Perrino, B.A., Howard, M., et al. (1995). Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267:108–111.
Cohen, P. (2002). Protein kinases – the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1:309–315.
Colbran, R.J. (2004). Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity. J. Neurosci. 24:8404–8409.
Collins, M.O., Yu, L., Coba, M.P., et al. (2005). Proteomic analysis of in vivo phosphorylated synaptic proteins. J. Biol. Chem. 280:5972–5982.
den Hertog, J., Groen, A., and van der Wijk, T. (2005). Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 434:11–15.
Ehrchen, J., Sunderkotter, C., Luger, T., et al. (2008). Calcineurin inhibitors for the treatment of atopic dermatitis. Expert Opin. Pharmacother. 9:3009–3023.
Faul, C., Donnelly, M., Merscher-Gomez, S., et al. (2008). The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14:931–938.
Faux, M.C. and Scott, J.D. (1996). More on target with protein phosphorylation: conferring specificity by location. Trends Biochem. Sci. 21:312–315.
Flavell, S.W., Cowan, C.W., Kim, T.K., et al. (2006). Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008–1012.
Forrest, A.R., Taylor, D.F., Fink, J.L., et al. (2006). PhosphoregDB: the tissue and sub-cellular distribution of mammalian protein kinases and phosphatases. BMC Bioinform 7:82.
Foster, T.C. (2007). Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 6:319–325.
Foster, T.C., Sharrow, K.M., Masse, J.R., et al. (2001). Calcineurin links Ca2+ dysregulation with brain aging. J. Neurosci. 21:4066–4073.
Ganesh, S., Delgado-Escueta, A.V., Sakamoto, T., et al. (2002). Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet. 11:1251–1262.
Ganesh, S., Puri, R., Singh, S., et al. (2006). Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J. Hum. Genet. 51:1–8.
Garton, A.J., Burnham, M.R., Bouton, A.H., et al. (1997). Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition. Oncogene 15:877–885.
Gebbink, M.F., Zondag, G.C., Wubbolts, R.W., et al. (1993). Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J. Biol. Chem. 268:16101–16104.
Gee, C.E. and Mansuy, I.M. (2005). Protein phosphatases and their potential implications in neuroprotective processes. Cell. Mol. Life Sci. 62:1120–1130.
Genoux, D., Haditsch, U., Knobloch, M., Michalon, A., Storm, D., and Mansuy, I.M. (2002). Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418:970–975.
Gingras, A.C., Caballero, M., Zarske, M., et al. (2005). A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol. Cell. Proteom 4:1725–1740.
Giovannini, M.G., Blitzer, R.D., Wong, T., et al. (2001). Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+/calmodulin-dependent protein kinase II in long-term potentiation. J. Neurosci. 21:7053–7062.
Goudreault, M., D’Ambrosio, L.M., Kean, M.J., et al. (2009). A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell. Proteom 8:157–171.
Greengard, P., Valtorta, F., Czernik, A.J., et al. (1993). Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780–785.
Griffin, T.J., Gygi, S.P., Ideker, T., et al. (2002). Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteom 1:323–333.
Hedou, G.F., Koshibu, K., Farinelli, M., et al. (2008). Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain. J. Neurosci. 28:154–162.
Hinsby, A.M., Olsen, J.V., and Mann, M. (2004). Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4. J. Biol. Chem. 279:46438–46447.
Honda, R., Ohba, Y., Nagata, A., et al. (1993). Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase. FEBS Lett. 318:331–334.
Honkanen, R.E. and Golden, T. (2002). Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? Curr. Med. Chem. 9:2055–2075.
Hooft van Huijsduijnen, R., Sauer, W.H., Bombrun, A., et al. (2004). Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem. 47:4142–4146.
Horne, E.A. and Dell’Acqua, M.L. (2007). Phospholipase C is required for changes in postsynaptic structure and function associated with NMDA receptor-dependent long-term depression. J. Neurosci. 27:3523–3534.
Hsieh, J. and Gage, F.H. (2005). Chromatin remodeling in neural development and plasticity. Curr. Opin. Cell Biol. 17:664–671.
Hsu, J.Y., Sun, Z.W., Li, X., Reuben, M., Tatchell, K., Bishop, D.K., Grushcow, J.M., Brame, C.J., Caldwell, J.A., Hunt, D.F., et al. (2000). Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102:279–291.
Huang, P.H. and White, F.M. (2008). Phosphoproteomics: unraveling the signaling web. Mol. Cell 31:777–781.
Hunter, T. (1998). The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353:583–605.
Husi, H., Ward, M.A., Choudhary, J.S., et al. (2000). Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3:661–669.
Jagiello, I., Beullens, M., Vulsteke, V., et al. (1997). NIPP-1, a nuclear inhibitory subunit of protein phosphatase-1, has RNA-binding properties. J. Biol. Chem. 272:22067–22071.
Jemc, J. and Rebay, I. (2007a). Identification of transcriptional targets of the dual-function transcription factor/phosphatase eyes absent. Dev. Biol. 310:416–429.
Jemc, J. and Rebay, I. (2007b). The eyes absent family of phosphotyrosine phosphatases: properties and roles in developmental regulation of transcription. Annu. Rev. Biochem. 76:513–538.
Jenuwein, T. and Allis, C.D. (2001). Translating the histone code. Science 293:1074–1080.
Jiang, Z.X. and Zhang, Z.Y. (2008). Targeting PTPs with small molecule inhibitors in cancer treatment. Cancer Metastasis Rev. 27:263–272.
Johnson, K.G., Tenney, A.P., Ghose, A., et al. (2006). The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 49:517–531.
Jouvenceau, A. and Dutar, P. (2006). A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J. Physiol. Paris 99:154–161.
Jouvenceau, A., Hedou, G., Potier, B., et al. (2006). Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur. J. Neurosci. 24:564–572.
Katayose, Y., Li, M., Al-Murrani, S.W., et al. (2000). Protein phosphatase 2A inhibitors, I(1)(PP2A) and I(2)(PP2A), associate with and modify the substrate specificity of protein phosphatase 1. J. Biol. Chem. 275:9209–9214.
Kim, Y.M., Watanabe, T., Allen, P.B., et al. (2003). PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit. Characterization of its PP1- and RNA-binding domains and regulation by phosphorylation. J. Biol. Chem. 278:13819–13828.
Kim, M.J., Dunah, A.W., Wang, Y.T., et al. (2005). Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46:745–760.
Klauck, T.M., Faux, M.C., Labudda, K., et al. (1996). Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 271:1589–1592.
Knobloch, M. and Mansuy, I.M. (2008). Dendritic spine loss and synaptic alterations in Alzheimer’s disease. Mol. Neurobiol. 37:73–82.
Koshibu, K., Graff, J., et al. (2009). Protein phosphatase 1 regulates the histone code for long-term memory. J. Neurosci. 29(41):13079–13089.
Kwon, C.H., Luikart, B.W., Powell, C.M., et al. (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377–388.
Landsverk, H.B., Kirkhus, M., Bollen, M., et al. (2005). PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner. Biochem. J. 390:709–717.
Laporte, J., Hu, L.J., Kretz, C., et al. (1996). A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:175–182.
Lee, H.K. (2006). Synaptic plasticity and phosphorylation. Pharmacol. Ther. 112:810–832.
Lee, S.R., Kwon, K.S., Kim, S.R., et al. (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:15366–15372.
Levenson, J.M. and Sweatt, J.D. (2005). Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci. 6:108–118.
Levenson, J.M. and Sweatt, J.D. (2006). Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. Cell. Mol. Life Sci. 63:1009–1016.
Levinthal, D.J. and Defranco, D.B. (2005). Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons. J. Biol. Chem. 280:5875–5883.
Li, L. and Dixon, J.E. (2000). Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin. Immunol. 12:75–84.
Li, X., Oghi, K.A., Zhang, J., Krones, A., et al. (2003). Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426:247–254.
Lin, J.W., Wyszynski, M., Madhavan, R., et al. (1998). Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J. Neurosci. 18:2017–2027.
Lisman, J., Schulman, H., and Cline, H. (2002). The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3:175–190.
Luebke, J.I., Chang, Y.M., Moore, T.L., et al. (2004). Normal aging results in decreased synaptic excitation and increased synaptic inhibition of layer 2/3 pyramidal cells in the monkey prefrontal cortex. Neuroscience 125:277–288.
Majeti, R., Bilwes, A.M., Noel, J.P., et al. (1998). Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88–91.
Majeti, R., Xu, Z., Parslow, T.G., et al. (2000). An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059–1070.
Malenka, R.C. and Nicoll, R.A. (1999). Long-term potentiation – a decade of progress? Science 285:1870–1874.
Malleret, G., Haditsch, U., Genoux, D., et al. (2001). Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104:675–686.
Manning, G., Whyte, D.B., Martinez, R., et al. (2002). The protein kinase complement of the human genome. Science 298:1912–1934.
Mansuy, I.M. (2003). Calcineurin in memory and bidirectional plasticity. Biochem. Biophys. Res. Commun. 311:1195–1208.
Mansuy, I.M. and Shenolikar, S. (2006). Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends Neurosci. 29:679–686.
McLean, J., Batt, J., Doering, L.C., et al. (2002). Enhanced rate of nerve regeneration and directional errors after sciatic nerve injury in receptor protein tyrosine phosphatase sigma knock-out mice. J. Neurosci. 22:5481–5491.
Miller, C.A. and Sweatt, J.D. (2007). Covalent modification of DNA regulates memory formation. Neuron 53:857–869.
Moorhead, G.B., Trinkle-Mulcahy, L., et al. (2007). Emerging roles of nuclear protein phosphatases. Nat. Rev. Mol. Cell. Biol. 8:234–244.
Moorhead, G.B., De Wever, V., Templeton, G., et al. (2009). Evolution of protein phosphatases in plants and animals. Biochem. J. 417:401–409.
Mulkey, R.M., Endo, S., Shenolikar, S., et al. (1994). Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369:486–488.
Mumby, M. (2007). PP2A: unveiling a reluctant tumor suppressor. Cell 130:21–24.
Munton, R.P., Vizi, S., and Mansuy, I.M. (2004). The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett. 567:121–128.
Munton, R.P., Tweedie-Cullen, R., Livingstone-Zatchej, M., et al. (2007). Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol. Cell. Proteom 6:283–293.
Nam, H.J., Poy, F., Krueger, N.X., Saito, H., et al. (1999). Crystal structure of the tandem phosphatase domains of RPTP LAR. Cell 97:449–457.
Neel, B.G., Gu, H., and Pao, L. (2003). The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284–293.
Niisato, K., Fujikawa, A., Komai, S., et al. (2005). Age-dependent enhancement of hippocampal long-term potentiation and impairment of spatial learning through the Rho-associated kinase pathway in protein tyrosine phosphatase receptor type Z-deficient mice. J. Neurosci. 25:1081–1088.
Norman, E.D., Thiels, E., Barrionuevo, G., et al. (2000). Long-term depression in the hippocampus in vivo is associated with protein phosphatase-dependent alterations in extracellular signal-regulated kinase. J. Neurochem. 74:192–198.
Norris, C.M., Halpain, S., and Foster, T.C. (1998). Alterations in the balance of protein kinase/phosphatase activities parallel reduced synaptic strength during aging. J. Neurophysiol. 80:1567–1570.
Nowak, S.J., Pai, C.Y., and Corces, V.G. (2003). Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster. Mol. Cell. Biol. 23:6129–6138.
Oficjalska-Pham, D., Harismendy, O., Smagowicz, W.J., et al. (2006). General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1. Mol. Cell 22:623–632.
Oliver, C.J., Terry-Lorenzo, R.T., Elliott, E., et al. (2002). Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology. Mol. Cell. Biol. 22:4690–4701.
Oliveria, S.F., Gomez, L.L., and Dell’Acqua, M.L. (2003). Imaging kinase – AKAP79 – phosphatase scaffold complexes at the plasma membrane in living cells using FRET microscopy. J. Cell Biol. 160:101–112.
Olsen, J.V., Blagoev, B., Gnad, F., et al. (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635–648.
Ostman, A., Hellberg, C., and Bohmer, F.D. (2006). Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6:307–320.
Pariser, H., Herradon, G., Ezquerra, L., et al. (2005a). Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C. Proc. Natl. Acad. Sci. USA 102:12407–12412.
Pariser, H., Perez-Pinera, P., Ezquerra, L., et al. (2005b). Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta. Biochem. Biophys. Res. Commun. 335:232–239.
Paul, S. and Lombroso, P.J. (2003). Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. Cell. Mol. Life Sci. 60:2465–2482.
Perez-Pinera, P., Alcantara, S., Dimitrov, T., Vega, J.A., and Deuel, T.F. (2006). Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc. Natl. Acad. Sci. USA 103:17795–17800.
Pulido, R., Zuniga, A., and Ullrich, A. (1998). PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17:7337–7350.
Qiu, Z. and Ghosh, A. (2008). A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 60:775–787.
Quinlan, E.M. and Halpain, S. (1996). Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron 16:357–368.
Ranish, J.A., Yi, E.C., Leslie, et al. (2003). The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 33:349–355.
Richards, E.J. (2006). Inherited epigenetic variation – revisiting soft inheritance. Nat. Rev. Genet. 7:395–401.
Roy, N., Van Eynde, A., Beke, L., et al. (2007). The transcriptional repression by NIPP1 is mediated by Polycomb group proteins. Biochim. Biophys. Acta 1769:541–545.
Salmeen, A. and Barford, D. (2005). Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid. Redox Signal. 7:560–577.
Schmidinger, H., Hermetter, A., and Birner-Gruenberger, R. (2006). Activity-based proteomics: enzymatic activity profiling in complex proteomes. Amino Acids 30:333–350.
Schones, D.E. and Zhao, K. (2008). Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet. 9:179–191.
Serratosa, J.M., Gomez-Garre, P., Gallardo, M.E., et al. (1999). A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet. 8:345–352.
Shalizi, A., Gaudilliere, B., Yuan, Z., et al. (2006). A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311:1012–1017.
Shenolikar, S. (2007). Analysis of protein phosphatases: toolbox for unraveling cell signaling networks. Methods Mol. Biol. 365:1–8.
Sim, A.T. and Scott, J.D. (1999). Targeting of PKA, PKC and protein phosphatases to cellular microdomains. Cell Calcium 26:209–217.
Sim, A.T., Baldwin, M.L., Rostas, et al. (2003). The role of serine/threonine protein phosphatases in exocytosis. Biochem J. 373:641–659.
Siniossoglou, S., Santos-Rosa, H., Rappsilber, J., et al. (1998). A novel complex of membrane proteins required for formation of a spherical nucleus. EMBO J. 17:6449–6464.
Smolen, P., Baxter, D.A., and Byrne, J.H. (2006). A model of the roles of essential kinases in the induction and expression of late long-term potentiation. Biophys. J. 90:2760–2775.
Snyder, E.M., Nong, Y., Almeida, C.G., et al. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8:1051–1058.
Stone, S.R., Hofsteenge, J., and Hemmings, B.A. (1987). Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. Biochemistry 26:7215–7220.
Strack, S., Kini, S., Ebner, F.F., et al. (1999). Differential cellular and subcellular localization of protein phosphatase 1 isoforms in brain. J. Comp. Neurol. 413:373–384.
Strack, S., McNeill, R.B., and Colbran, R.J. (2000). Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 275:23798–23806.
Tabernero, L., Aricescu, A.R., Jones, E.Y., et al. (2008). Protein tyrosine phosphatases: structure-function relationships. FEBS J. 275:867–882.
Tailor, P., Gilman, J., Williams, S., et al. (1997). Regulation of the low molecular weight phosphotyrosine phosphatase by phosphorylation at tyrosines 131 and 132. J. Biol. Chem. 272:5371–5374.
Tamura, H., Fukada, M., Fujikawa, A., et al. (2006). Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP. Neurosci. Lett. 399:33–38.
Tautz, L., Pellecchia, M., and Mustelin, T. (2006). Targeting the PTPome in human disease. Expert Opin. Ther. Targets 10:157–177.
Tezuka, T., Umemori, H., Akiyama, T., et al. (1999). PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc. Natl. Acad. Sci. USA 96:435–440.
Thiels, E., Kanterewicz, B.I., Knapp, L.T., et al. (2000). Protein phosphatase-mediated regulation of protein kinase C during long-term depression in the adult hippocampus in vivo. J. Neurosci. 20:7199–7207.
Tonks, N.K. (2005). Redox redux: revisiting PTPs and the control of cell signaling. Cell 121:667–670.
Tonks, N.K. (2006). Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell. Biol. 7:833–846.
Tootle, T.L., Silver, S.J., Davies, E.L., et al. (2003). The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature 426:299–302.
Trelle, M.B. and Jensen, O.N. (2007). Functional proteomics in histone research and epigenetics. Expert Rev. Proteom 4:491–503.
Trinidad, J.C., Thalhammer, A., Specht, C.G., et al. (2005). Phosphorylation state of postsynaptic density proteins. J. Neurochem. 92:1306–1316.
Trinidad, J.C., Specht, C.G., Thalhammer, A., et al. (2006). Comprehensive identification of phosphorylation sites in postsynaptic density preparations. Mol. Cell. Proteom 5:914–922.
Trinidad, J.C., Thalhammer, A., Specht, C.G., et al. (2008). Quantitative analysis of synaptic phosphorylation and protein expression. Mol. Cell. Proteom 7:684–696.
Trinkle-Mulcahy, L., Andersen, J., Lam, Y.W., et al. (2006). Repo-Man recruits PP1 gamma to chromatin and is essential for cell viability. J. Cell Biol. 172:679–692.
Tsankova, N., Renthal, W., Kumar, A., et al. (2007). Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8:355–367.
Tweedie-Cullen, R.Y., Wollscheid, B., Livingstone-Zatchej, M., et al. (2007). Neuroproteomics and the detection of regulatory phosphosites. Curr. Proteom 4:209–222.
Ubersax, J.A. and Ferrell, J.E., Jr. (2007). Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell. Biol. 8:530–541.
Ulke-Lemee, A., Trinkle-Mulcahy, L., Chaulk, S., et al. (2007). The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G. Biochim. Biophys. Acta 1774:1339–1350.
Vagnarelli, P., Hudson, D.F., Ribeiro, S.A., et al. (2006). Condensin and Repo-Man-PP1 co-operate in the regulation of chromosome architecture during mitosis. Nat.Cell Biol. 8:1133–1142.
van der Wijk, T., Overvoorde, J., and den Hertog, J. (2004). H2O2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. J. Biol. Chem. 279:44355–44361.
Vulsteke, V., Beullens, M., Waelkens, E., et al. (1997). Properties and phosphorylation sites of baculovirus-expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1). J. Biol. Chem. 272:32972–32978.
Wang, J.H. and Kelly, P.T. (1996). The balance between postsynaptic Ca(2+)-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn. Mem. 3:170–181.
Wang, Y.T. and Salter, M.W. (1994). Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369:233–235.
Wang, X., Culotta, V.C., and Klee, C.B. (1996). Superoxide dismutase protects calcineurin from inactivation. Nature 383:434–437.
Watson, J.B., Khorasani, H., Persson, A., et al. (2002). Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. J. Neurosci. Res. 70:298–308.
Westphal, R.S., Tavalin, S.J., Lin, J.W., et al. (1999). Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285:93–96.
Winder, D.G. and Sweatt, J.D. (2001). Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat. Rev. Neurosci. 2:461–474.
Wishart, M.J. and Dixon, J.E. (2002). PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Trends Cell Biol. 12:579–585.
Xu, Z. and Weiss, A. (2002). Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764–771.
Yakel, J.L. (1997). Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol. Sci. 18:124–134.
Yin, Y. and Shen, W.H. (2008). PTEN: a new guardian of the genome. Oncogene 27:5443–5453.
Zhang, Y., Kim, Y., Genoud, N., et al. (2006). Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. Mol. Cell 24:759–770.
Zhang, S., Edelmann, L., Liu, J., et al. (2008). Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors. J. Neurosci. 28:415–424.
Zhou, F., Galan, J., Geahlen, R.L., et al. (2007). A novel quantitative proteomics strategy to study phosphorylation-dependent peptide-protein interactions. J. Proteom Res. 6:133–140.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tweedie-Cullen, R.Y., Park, C.S., Mansuy, I.M. (2011). Protein Phosphatases in the Brain: Regulation, Function and Disease. In: Vidal, C. (eds) Post-Translational Modifications in Health and Disease. Protein Reviews, vol 13. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6382-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6382-6_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6381-9
Online ISBN: 978-1-4419-6382-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)